Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-05-29 00:00:00 ET · period of report 2025-05-27 · accession 0000950170-25-079229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-05-29 | 2025-05-27+ | AXSM | Coleman Mark | Dir | S - Sale | $104.45 | -7,500 | 46.6K | -14% | -$783.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-27 | S | D | 3,750 | $105.47 | 50,387 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $104.75 and $106.50. |
| 2 | Common | Common Stock | 2025-05-28 | S | D | 3,750 | $103.43 | 46,637 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $102.71 and $104.38. |